Evidence map›Paper›PMID 41163911›Full record

ArticleAnnals of thoracic surgery short reports2025

Endovascular Repair vs Medical Therapy for Uncomplicated Acute Type B Dissection: Aortic Remodeling.

Adrian Acuna Higaki, Irbaz Hameed, Ely Erez, Kevin G Hu, Sem Asmelash, Devina Chatterjee, Benjamin Shou, Mohammad Zafar, Roland Assi, Prashanth Vallabhajosyula

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of thoracic surgery short reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adrian Acuna HigakiDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Irbaz HameedDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Ely ErezDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Kevin G HuDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Sem AsmelashDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Devina ChatterjeeSchool of Medicine, University of Maryland, Baltimore, Maryland.
Benjamin ShouJohns Hopkins University School of Medicine, Baltimore, Maryland.
Mohammad ZafarDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Roland AssiDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Prashanth VallabhajosyulaDivision of Cardiac Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.

Funding

Short Term Research Training: Students in Health Professional SchoolsT35DK104689 · NIDDK · YALE UNIVERSITY · PI LLOYD G CANTLEY, Sarwat I Chaudhry · 2015 to 2026
$2.6M
NIDDK NIH HHS T35 DK104689
6 · The paper itself

Abstract

Background: The optimal initial management for uncomplicated acute type B aortic dissection (uATBAD) remains unclear. We evaluated 1-year aortic remodeling and clinical outcomes of thoracic endovascular aortic repair (TEVAR) vs exclusively optimal medical therapy for uATBAD. Methods: Patients with uATBAD were retrospectively grouped by initial treatment modality, with 52 patients treated with TEVAR and 142 with optimal medical therapy. Clinical outcomes and aortic remodeling were compared at presentation and 1-year follow-up. Aortic remodeling parameters, including change in true lumen diameter, full lumen diameter, and true lumen index, and extent of false lumen thrombosis were assessed at 12 thoracoabdominal levels and compared between treatment groups. Results: TEVAR had lower 30-day/in-hospital mortality than optimal medical therapy (0% vs 11.3%; Conclusions: TEVAR was associated with favorable aortic remodeling as well as short-term and midterm outcomes compared with optimal medical therapy in patients with uATBAD. The positive remodeling is more pronounced at thoracic aortic levels.

Identifiers

PMID41163911
PMCPMC12559255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.